Who owns iShares Dow Jones US Pharm Indx?

Key details on iShares Dow Jones US Pharm Indx (Ticker: IHE)

Who owns iShares Dow Jones US Pharm Indx?

Is IHE a good stock to own? Find out who bought iShares Dow Jones US Pharm Indx, who sold iShares Dow Jones US Pharm Indx (IHE) stock, and who holds a large position in iShares Dow Jones US Pharm Indx.

Fund Name Number of Shares Share Valuation As Of
Bank of America Corporation 290276 $40.68M Sept. 30, 2014
MORGAN STANLEY 277353 $39.17M Sept. 30, 2014
Niemann Capital Management 184992 $16.58M Sept. 30, 2012
Wells Fargo & Company 152543 $20.80M June 30, 2014
GOLDMAN SACHS 102746 $7.85M Dec. 31, 2011
FMR 98689 $9.83M June 30, 2013
Brown Advisory Holdings Incorporated 88998 $12.46M Sept. 30, 2014
BANK OF MONTREAL /CAN/ 88417 $12.41M Sept. 30, 2014
Royal Bank of Canada 68284 $9.58M Sept. 30, 2014
Clark Capital Management 62550 $7.92M March 31, 2014
Raymond James Financial Services Advisors 60259 $8.46M Sept. 30, 2014
SPC Financial 59609 $8.37M Sept. 30, 2014
Rafferty Asset Management 57900 $5.77M June 30, 2013
CLS Investments 57000 $7.22M March 31, 2014
Raymond James & Associates 53730 $7.54M Sept. 30, 2014
Knight Capital 51820 $4.41M Dec. 31, 2012
Guggenheim Capital, LLC Managers 51138 $4.25M March 31, 2012
LPL Financial 48784 $6.79M Sept. 30, 2014
Braver Wealth Management 48051 $6.49M June 30, 2014
SPINNAKER TRUST 44900 $6.30M Sept. 30, 2014
PICTET ASSET MANAGEMENT 43190 $4.59M Sept. 30, 2013
MURPHY CAPITAL MANAGEMENT 42780 $6.00M Sept. 30, 2014
Stifel, Nicolaus & Company, Incorporated 41334 $3.58M June 30, 2012
SUSQUEHANNA INTERNATIONAL 40719 $5.71M Sept. 30, 2014
STRINGER ASSET MANAGEMENT 39432 $5.33M June 30, 2014
Tower Research Capital 37634 $4.77M March 31, 2014
Polaris Equity Management 36110 $3.24B Sept. 30, 2012
UBS AG 34328 $4.82M Sept. 30, 2014

Who sold iShares Dow Jones US Pharm Indx?

Fund Name Date Sold Number of Shares Sold Share Valuation
First Heartland Consultants June 30, 2011 41896 $571042
RiverFront Investment Sept. 30, 2010 39107 $2.39M